Corrigendum to Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1 α/miR-494/Survivin signaling pathway [Volume 32 Number xxx Month 2022 pp. 100821]

Detalles Bibliográficos
Autores principales: Li, Hongchang, Su, Xianhao, Li, Jindong, Liu, Weiyan, Pan, Gaofeng, Mao, Anwei, Liu, Jiazhe, Zhang, Qing, Rao, Longhua, Xie, Xiaofeng, Sheng, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Erratum/Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630038/
https://www.ncbi.nlm.nih.gov/pubmed/37873727
http://dx.doi.org/10.1016/j.neo.2022.100843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630038/
https://www.ncbi.nlm.nih.gov/pubmed/37873727
http://dx.doi.org/10.1016/j.neo.2022.100843

Ejemplares similares